{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:44:07Z","timestamp":1777632247906,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.amjcard.2026.02.062","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:38:41Z","timestamp":1772177921000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The Effect of Vericiguat on Endothelial Function in Patients With Heart Failure With Reduced Ejection Fraction: A Pilot Randomized Study"],"prefix":"10.1016","volume":"266","author":[{"given":"Konstantinos","family":"Sideris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanokwan","family":"Bunsawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Brinker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarred","family":"Iacovelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonah M.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Tseliou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos P.","family":"Kyriakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Hanff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Florido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison M.","family":"Brann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Walter","family":"Wray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7362-0513","authenticated-orcid":false,"given":"Josef","family":"Stehlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.02.062_bib0001","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027852","article-title":"Trends, and Inequalities of Heart Failure Globally, 1990 to 2019: A Secondary Analysis Based on the Global Burden of Disease 2019 Study","volume":"12","author":"Yan","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0003","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global Public Health Burden of Heart Failure: An Updated Review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0004","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-023-01887-4","article-title":"Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction","volume":"83","author":"Patel","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0005","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0006","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/cts.13677","article-title":"Vericiguat, a novel sGC stimulator: Mechanism of action, clinical, and translational science","volume":"16","author":"Trujillo","year":"2023","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0007","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0008","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial","volume":"314","author":"Gheorghiade","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0009","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ejhf.2836","article-title":"Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudy","volume":"25","author":"Pieske","year":"2023","journal-title":"European journal of heart failure"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0010","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1113\/EP088686","article-title":"Chronic antioxidant administration restores macrovascular function in patients with heart failure with reduced ejection fraction","volume":"105","author":"Bunsawat","year":"2020","journal-title":"Exp Physiol"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0011","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.CIR.93.2.210","article-title":"Physical training improves endothelial function in patients with chronic heart failure","volume":"93","author":"Hornig","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0012","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/HYPERTENSIONAHA.112.193318","article-title":"Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond","volume":"60","author":"Witman","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0013","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/clc.22468","article-title":"Correlation of the New York Heart Association Classification and the 6-Minute Walk Distance: A Systematic Review","volume":"38","author":"Yap","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0014","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1152\/japplphysiol.00454.2020","article-title":"Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction","volume":"130","author":"Bunsawat","year":"2021","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0015","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/0002-9149(92)90710-G","article-title":"Endothelial function in chronic congestive heart failure","volume":"69","author":"Drexler","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0016","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function: from research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.110.167015","article-title":"Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?","volume":"57","author":"Green","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0018","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/HYPERTENSIONAHA.110.150821","article-title":"Ultrasound assessment of flow-mediated dilation","volume":"55","author":"Harris","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0019","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/eurheartj\/ehi259","article-title":"The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure","volume":"26","author":"Ingle","year":"2005","journal-title":"European heart journal"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0020","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0021","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/ehf2.15206","article-title":"Health-related quality of life across heart failure categories: associations with clinical characteristics and outcomes","volume":"12","author":"Settergren","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0022","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.107.759191","article-title":"Tumor necrosis factor-alpha and mortality in heart failure: a community study","volume":"118","author":"Dunlay","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0023","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"European journal of heart failure"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0024","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cyto.2013.09.018","article-title":"Reference range and short- and long-term biological variation of interleukin (IL)-6, IL-17A and tissue necrosis factor-alpha using high sensitivity assays","volume":"64","author":"Todd","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0025","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(25)01665-4","article-title":"Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial","volume":"406","author":"Butler","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mayocpiqo.2018.12.006","article-title":"Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure","volume":"3","author":"Premer","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0027","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1071-9164(03)00585-2","article-title":"Reduced vascular compliance is associated with impaired endothelium-dependent dilatation in the brachial artery of patients with congestive heart failure","volume":"10","author":"Nakamura","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0028","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3390\/diagnostics14222499","article-title":"A Comprehensive Review of Clinical Studies Applying Flow-Mediated Dilation","volume":"14","author":"Ahn","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0029","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1161\/HYPERTENSIONAHA.120.15754","article-title":"Reference Intervals for Brachial Artery Flow-Mediated Dilation and the Relation With Cardiovascular Risk Factors","volume":"77","author":"Holder","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.phrs.2010.06.008","article-title":"Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure","volume":"62","author":"Schafer","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.709703","article-title":"The Role of the Inflammasome in Heart Failure","volume":"12","author":"Wu","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0032","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/ejhf.1787","article-title":"Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction","volume":"22","author":"Kramer","year":"2020","journal-title":"European journal of heart failure"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0033","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0036-1597577","article-title":"Nitric Oxide: Link between Inflammation and Endothelial Dysfunction in Rheumatoid Arthritis","volume":"26","author":"Garg","year":"2017","journal-title":"Int J Angiol"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0034","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3390\/ijms20081820","article-title":"BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine","volume":"20","author":"Cao","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jchf.2022.04.015","article-title":"Sequential Evaluation of NT-proBNP in Heart Failure: Insights Into Clinical Outcomes and Efficacy of Vericiguat","volume":"10","author":"Armstrong","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0036","article-title":"Vericiguat in patients with heart failure across the spectrum of left ventricular ejection fraction: a patient-level, pooled meta-analysis of VITALITY-HFpEF and VICTORIA","volume":"15","author":"Chen","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0037","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jacc.2018.11.049","article-title":"Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction","volume":"73","author":"Butler","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0038","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/eurheartj\/ehaa1007","article-title":"Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial","volume":"42","author":"Butler","year":"2021","journal-title":"European heart journal"},{"key":"10.1016\/j.amjcard.2026.02.062_bib0039","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2016.03.011","article-title":"Adherence to guidelines strongly improves reproducibility of brachial artery flow-mediated dilation","volume":"248","author":"Greyling","year":"2016","journal-title":"Atherosclerosis"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:56:34Z","timestamp":1777434994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"alternative-id":["S0002914926001141"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.02.062","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Vericiguat on Endothelial Function in Patients With Heart Failure With Reduced Ejection Fraction: A Pilot Randomized Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.02.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}